J-STAGE Home  >  Publications - Top  > Bibliographic Information

bioimages
Vol. 25 (2017) p. 7-19

Language:

http://doi.org/10.11169/bioimages.25.7

Regular Article

Aurora B kinase activity is known to be required for chromosome alignment, segregation and cytokinesis. Its function in vivo has been characterized with small-molecule inhibitors, such as ZM447439, Hesperadin and VX-680. Since the inhibition of Aurora B kinase often results in a premature exit of mitosis without chromosome alignment, the events after chromosome segregation have yet to be fully analyzed. To monitor the typical events of mitosis and cytokinesis in the living state, we constructed two fluorescent human melanoma MDA-MB-435S cell lines, expressing mPlum-histoneH3/EGFP-survivin or mPlum-histone-H3/mOrange-actin. We examined the effect of the Aurora B kinase inhibitor AZD1152-HQPA on the entire process from the initiation of mitosis to the completion of cytokinesis. We extensively captured live cell images using a multi-point time lapse imaging system equipped with a PlanApo 60x objective. Although most of the mitotic cells showed premature mitotic exit, some populations of the cells proceeded to anaphase but failed to complete cytokinesis, resulting in binucleated cells. In these cells, we noticed that a chromosome bridge had been formed at the cleavage site during chromosome segregation and that the bridge was maintained after the ingression of the cleavage furrow, known as an “anaphase bridge” in mis-segregating cells. The cytokinesis of these cells was ultimately interrupted with the cleavage furrow regression. A multi-point time lapse imaging analysis of a nonsynchronous, randomly growing cell culture in a higher magnification would be useful for characterizing the real-time effects of other Aurora kinase-inhibitors in living cells.

Copyright © Bioimaging Society

Article Tools

  • Add to Favorites
  • Citation Alert
  • Authentication Alert
  • Additional Info Alert
  • Copy the URL
  • Download Meta of Article
  • RIS
  • BibTeX
  • [ Help ]
  • Contact us

Share this Article